RE:RE:RE:RE:RE:RE:RE:60% of the road = 270-daysLaser, whe we meet in Vegas. After this adventure is over, you'll have to bring along some of your stash, I'd like to sample some... ;-)
LaserStock29 wrote: Rumpl3StiltSkin wrote: LaserStock29 wrote: Camphikefish wrote: Looks like we need to come in at 25-30 % at a minimum with our 12 month CR data. Thoughts on our chances/probability?
3/10 was known wayback 1993 photofrin 60% w damages to organ 2022 we better minimum be over 60%
I believe since NMIBC, via instilations, is so in-exact. We might be doing pretty well with %s in the 40s or 50s. Maybe we get as high as the 60s after AA and the much higher numbers of patients. Solid tumor indications is I think where TLT could see very high percentages.
Of course the best thing about TLTs ACT is how safe and repeatable it is. Turning NRs to PRs to CRs.
Sure, I wish some of this was priced in to the stock by now.....
Why not just do the pp now. The world is just getting tougher now to live. Same terms as 2019 for canadians 1 + 1 warrant free trading. . We've already treated 41. 11 still eed 2nd treatment. Eoy is no.25 at 450 Our trial is over. The only way we should be treating is the next phase in usa with BTD and AA for the latter 80 patients. At a $2 pps